Few Positive Prevention interventions have been implemented in Africa; however, greater attention is now being paid to interventions that include messages of personal responsibility or altruism that may motivate HIV-infected …
Purpose - The purpose of this paper is to establish socio-economic factors and maternal practices that determine child mortality in Uganda.Design/methodology/approach - The paper examines the role of sex, birth …
Background: Impact evaluation of vaccination programs is necessary for making decisions to introduce oral cholera vaccines (OCVs) in cholera-endemic countries.Methods: We analyzed data to forecast the future global burden of …
Biorepositories in Africa need significant infrastructural support to meet International Society for Biological and Environmental Repositories (ISBER) Best Practices to support population-based genomics research. ISBER recommends a biorepository information management …
Nurses in Jamaica, Kenya, South Africa, and Uganda are at risk for occupational exposure to HIV. Little is known about the experiences and policy supports related to nurses having themselves …
The majority of children living with HIV/AIDS reside in sub-Saharan Africa. Most children become HIV-infected through mother-to-child transmission (MTCT). Methods used to prevent MTCT include antiretroviral therapy (ART), caesarean section, …
Oral pre-exposure prophylaxis (PrEP) is highly effective and could bring us closer to HIV elimination targets if offered alongside testing and treatment. However, this effective HIV prevention intervention is only …
Background: Pulmonary aspergillosis (PA) is common among patients with tuberculosis (TB). With both infections presenting with similar clinical and radiologic features, diagnosis of PA is often made too late or …
The unprecedented 2014-2015 Ebola virus disease (EVD) outbreak in West Africa has highlighted the need for effective therapeutics against filoviruses. Monoclonal antibody (MAb) cocktails have shown great potential as EVD …
BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …